The verified properties also explained, why certain single-gene targeted therapies, for example, the RB- and PTEN-treatment, might not always inhibit the growth of pancreatic cancer cells, due to the crosstalk of different signaling pathways, even if some pathway is blocked. The gene discussed is PTEN; the disease is familial pancreatic carcinoma.